Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories.
To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
----------------------------------------------
** BREAST CANCER News **
British Study Shows Possible Explanation For Tamoxifen Resistance In Some Breast Cancer Patients
http://www.medicalnewstoday.com/articles/129555.php
<BR>British researchers have discovered a possible explanation for why some female breast cancer patients being treated with tamoxifen -- the most commonly used breast cancer drug -- are resistant to the treatment, increasing their risk that tumors will return, according to a <A href="http://www.
----------------------------------------------
** CANCER / ONCOLOGY News **
SciClone Agreement With FDA On Special Protocol Assessment For Phase 3 Thymalfasin Trial In Stage IV Melanoma
http://www.medicalnewstoday.com/articles/129670.php
SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that the Company and the U.S. Food and Drug Administration (FDA) have reached agreement on the design of a phase 3 registration trial for thymalfasin as a potential treatment for stage IV melanoma.
Plymouth Hospitals To Lead Cancer Surgery Training Programme, England
http://www.medicalnewstoday.com/articles/129636.php
Plymouth Hospitals NHS Trust has been chosen to co-ordinate the national programme for the training of existing consultants in advanced keyhole surgery for the treatment of bowel cancer. The Department of Health has appointed Consultant General Surgeon, Mr Mark Coleman as the National Clinical Lead for the Laparoscopic Colorectal Cancer Surgery Training Programme.
Main Reason Teens Get Sunburnt "I Forgot To Protect Myself"
http://www.medicalnewstoday.com/articles/129608.php
Teens continue to put themselves at unnecessary risk of skin cancer by spending excessive time in the sun and forgetting to protect themselves, according to new Cancer Council research. Findings from the Cancer Council's National Sun Protection Survey released today show teens spend an average of two hours (1hr 51mins) in the sun during peak UV, with almost a third who get sunburnt saying they "forgot" to protect themselves.
Cytopia Doses First Brain Cancer Patient In Phase Ib/II Study
http://www.medicalnewstoday.com/articles/129604.php
Cytopia Limited (ASX:CYT) has commenced dosing patients in its Phase Ib/II study of CYT997, the company's novel vascular-disrupting anticancer agent, to treat glioblastoma multiforme (GBM), an aggressive brain cancer.
The Genetics Of Aging And Cancer Resistance
http://www.medicalnewstoday.com/articles/129589.php
In the November 15th issue of <i>G&D</i>, Dr. Kenneth Dorshkind and colleagues at the David Geffen School of Medicine (UCLA) have identified two genes - p16(Ink4a) and Arf - that sensitize lymphoid progenitor cells to the effects of aging, and confer resistance to leukemogenesis.
Efforts, Grants Seek To Raise Cancer Awareness Among Alaska Natives, Educate Elderly Hispanics On Diabetes Management, Target Infant Mortality
http://www.medicalnewstoday.com/articles/129578.php
The following is a summary of efforts and grants that seek to reduce racial and ethnic health disparities. <ul><li class="AdvisoryBullet"><a href="http://www.anthc.org/" target="_new">Alaska Native Tribal Health Consortium</a>: The <a href="http://www.
----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **
Four-type HPV Vaccine Gardasil(R) Is Also Effective In Men
http://www.medicalnewstoday.com/articles/129676.php
The four-type (6,11,16,18) human papillomavirus (HPV) vaccine Gardasil® is also effective in men according to the primary analysis from a pivotal phase III clinical study. In previously uninfected men aged 16 to 26 years*, Gardasil® prevented 90% (95%CI: 69, 98) of external genital lesions caused by HPV types 6, 11, 16 or 18.
New Research Shows Knowledge Of HPV And Vaccination Could Improve Cervical Screening Attendance
http://www.medicalnewstoday.com/articles/129616.php
Information about vaccination against the virus that causes cervical cancer could encourage rather than discourage women to attend for cervical screening, a new survey has found.1A number of commentators have said that vaccinating women against the human papillomavirus (HPV), which causes cervical cancer, could make them complacent about attending for cervical screening (smear test), although to date there has been no evidence to support this.
New Data On Cancer Diagnostic Presented By Arbor Vita
http://www.medicalnewstoday.com/articles/129590.php
Arbor Vita Corporation (AVC), a privately held biopharmaceutical company, presented new data on its rapid, point-of-care prototype HPV test with a high positive predictive value for cervical cancer and pre-cancer.
----------------------------------------------
** COLORECTAL CANCER News **
OncoVAX, Other Vaccines Provide Hope For Colorectal Cancer Treatment, Prevention
http://www.medicalnewstoday.com/articles/129643.php
Propelled by advances in molecular biology, the treatment of colorectal cancer is on the verge of dramatic change and a promising future as innovative vaccines will replace chemotherapy.
----------------------------------------------
** LUNG CANCER News **
First Pivotal Trials Begin For Boehringer Ingelheim's Novel Triple Angiokinase Inhibitor Vargatef™ (BIBF 1120)
http://www.medicalnewstoday.com/articles/129626.php
Boehringer Ingelheim has marked a new milestone within its rapidly expanding oncology portfolio with the announcement today that the company has progressed another of its oncology compounds into pivotal phase III clinical development.
----------------------------------------------
** LYMPHOMA / LEUKEMIA News **
No news for this category today.
----------------------------------------------
** PROSTATE / PROSTATE CANCER News **
Nymox Reports Positive New Results In 59 Week Study Of Drug For Enlarged Prostate
http://www.medicalnewstoday.com/articles/129620.php
Nymox Pharmaceutical Corporation (NASDAQ:NYMX) is pleased to announce positive new results from the Company's most recent study of NX-1207, its drug in development for benign prostatic hyperplasia (BPH).
Cardium's InnerCool Announces New Tissue-Specific UroCool(TM) System For Use In Prostate Surgeries
http://www.medicalnewstoday.com/articles/129597.php
Cardium Therapeutics (Amex: CXM) and its operating unit InnerCool Therapies, Inc., today announced that it has developed a pelvic cooling catheter system called UroCool(TM), which is designed to induce localized cooling during surgery for prostate cancer (radical prostatectomy).
-------------------------------------------------------------
You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
No comments:
Post a Comment